Tuya Developer Day at CES 2026 Brings Together Global Industry Leaders to Discuss the Future of Physical AI
LAS VEGAS, Jan. 8, 2026 /PRNewswire/ — On January 7, 2026, at the globally renowned consumer electronics event CES 2026, Tuya Smart (NYSE: TUYA, HKEX: 2391),... Read more.
Akkadian Names Andrea Gasior as Chief Revenue Officer
Seasoned revenue leader joins Akkadian to scale growth, expand unified communications solutions, and deepen enterprise customer partnerships NEW YORK, Jan. 8, 2026... Read more.
Jacobs Appointed Engineering, Procurement and Construction Management Lead for Hut 8 AI Data Center
Advancing high-performance computing infrastructure in North America DALLAS, Jan. 8, 2026 /PRNewswire/ — Jacobs (NYSE: J) has been selected by Hut 8 (NASDAQ:... Read more.
Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women’s and Children’s Healthcare
Proven to Reduce Preterm Births, NICU Admissions, and Costs, Pomelo Now Covers Nearly 7% of U.S. Births and Is Expanding to Deliver Evidence-Based Care for Women... Read more.
Hisense Debuts 116UXS and XR10 at CES 2026, Advancing RGB MiniLED into a New Era
DUBAI, United Arab Emirates, Jan. 8, 2026 /PRNewswire/ — Hisense, a leading brand in global consumer electronics and home appliances, unveiled the 116UXS RGB... Read more.
Sunwoda Joins 2026 Sungrow Global Partners Conference to Deepen Global Collaboration and Sustainability
HEFEI, China, Jan. 8, 2026 /PRNewswire/ — On January 8, Sunwoda, as a global partner of Sungrow, attended the 2026 Sungrow Global Partners Conference in Hefei,... Read more.
DMD Earns Third Consecutive Recognition on the 2026 Real Leaders® Top Impact Companies List
TEMPE, Ariz., Jan. 8, 2026 /PRNewswire/ — DMD Systems Recovery, LLC (DMD), a Reuse First® IT Asset Disposition (ITAD) provider and Certified B Corporation,... Read more.
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable colorectal cancer (MSS-CRC) Company... Read more.
Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference
FDA End-of-Phase 2 meeting scheduled to take place in the first quarter of 2026 for the chronic cough program in patients with idiopathic pulmonary fibrosis Phase... Read more.
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
LAUSANNE, Switzerland, Jan. 8, 2026 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody... Read more.